Literature DB >> 26117246

Oxidative stress in bipolar and schizophrenia patients.

Özgür Korhan Tunçel1, Gökhan Sarısoy2, Birşen Bilgici3, Ozan Pazvantoglu2, Eda Çetin2, Esra Ünverdi2, Bahattin Avcı3, Ömer Böke2.   

Abstract

Oxidative stress has an important place in studies investigating the pathophysiology of psychiatric diseases. In spite of this fact, longitudinal studies are required to clarify the subject. Therefore, in this study, we examined lipid peroxidation, protein oxidation, total oxidized guanine species, superoxide dismutase (SOD) and total glutathione (GSH) levels in blood collected from adult bipolar patients (n=18) during manic and euthymic episodes, schizophrenic patients (n=18) during acute psychotic attack and remission phases and the control group (n=18). There was a significant increase in the level of lipid peroxidation in the bipolar disorder manic episode group (BD-ME) compared to control group. The level of protein oxidation was significantly higher in the schizophrenia acute psychotic attack group (SZ-APA) compared to the control group. The level of total oxidized guanine species was statistically higher in all psychiatric groups compared to the control group. There was no significant difference among the groups with regard to SOD and GSH. Consequently, we believe that lipid peroxidation may be effective in the pathogenesis of bipolar patients; that protein oxidation may be of importance in the pathogenesis of schizophrenia and that total oxidized guanine species may be crucial in the pathogeneses of both psychiatric disorders.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Glutathione; Lipid peroxidation; Oxidized guanine; Protein oxidation; Psychiatric disorders; Superoxide dismutase

Mesh:

Substances:

Year:  2015        PMID: 26117246     DOI: 10.1016/j.psychres.2015.04.046

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

Review 2.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

Review 3.  Redox theory of aging: implications for health and disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Clin Sci (Lond)       Date:  2017-06-30       Impact factor: 6.124

Review 4.  Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.

Authors:  Luiz Arthur Rangel Cyrino; Daniela Delwing-de Lima; Oliver Matheus Ullmann; Thayná Patachini Maia
Journal:  Front Behav Neurosci       Date:  2021-02-26       Impact factor: 3.558

5.  Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.

Authors:  Xi Rong Li; Mei Hong Xiu; Xiao Ni Guan; Yue Chan Wang; Jun Wang; Edison Leung; Xiang Yang Zhang
Journal:  Neurotherapeutics       Date:  2021-03-31       Impact factor: 7.620

6.  Increased DNA and RNA damage by oxidation in patients with bipolar I disorder.

Authors:  A S Jacoby; M Vinberg; H E Poulsen; L V Kessing; K Munkholm
Journal:  Transl Psychiatry       Date:  2016-08-09       Impact factor: 6.222

7.  Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients.

Authors:  Kärt Kriisa; Liina Haring; Eero Vasar; Kati Koido; Sven Janno; Veiko Vasar; Kersti Zilmer; Mihkel Zilmer
Journal:  Oxid Med Cell Longev       Date:  2016-07-27       Impact factor: 6.543

8.  The complex association between the antioxidant defense system and clinical status in early psychosis.

Authors:  Saínza García; Susana Alberich; Mónica Martínez-Cengotitabengoa; Celso Arango; Josefina Castro-Fornieles; Mara Parellada; Inmaculada Baeza; Carmen Moreno; Juan Antonio Micó; Esther Berrocoso; Montserrat Graell; Soraya Otero; Tatiana Simal; Ana González-Pinto
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

9.  Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry.

Authors:  L G Nucifora; T Tanaka; L N Hayes; M Kim; B J Lee; T Matsuda; F C Nucifora; T Sedlak; R Mojtabai; W Eaton; A Sawa
Journal:  Transl Psychiatry       Date:  2017-08-22       Impact factor: 6.222

10.  Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population.

Authors:  Ci Yan; Li Duan; Chunfeng Fu; Chunsheng Tian; Bihui Zhang; Xiaojun Shao; Gang Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-18       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.